Article

Identification of immune subtypes and response prediction to immune-checkpoint inhibitors for MDM4 gain/amplification luminal A type breast cancer

2023-05-23

Abstract excerpt

<title>Abstract</title><p><bold>Objective:</bold>The aim of this work was to identify the consensus immune subtypes and predict the response to immune checkpoint inhibitor (ICIs) therapy for MDM4 gain/amplification luminal A type breast cancer (BC).<bold>Materials and Methods:</bold>Luminal A type BC expression data, copy number and corresponding clinical information were downloaded and pre-processed for subsequen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 189d8bce-90b0-55d8-baff-ade8b194bd48
DOI: 10.21203/rs.3.rs-2954307/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of immune subtypes and response prediction to immune-checkpoint inhibitors for MDM4 gain/amplification luminal A type breast cancerDOI 10.21203/rs.3.rs-2954307/v1Read

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune MicroenvironmentSemantic proximity Read

A novel immune checkpoint-related signature for prognosis and immune analysis in breast cancer.Semantic proximity Read

Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell TranscriptomesSemantic proximity Read

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscapeSemantic proximity Read

A key molecular driver of tumor-infiltrating lymphocytes in invasive breast cancer on machine learning–based meta-mining researchSemantic proximity Read

Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune ActivitySemantic proximity Read

A comprehensive analysis based on classification of immunogenic cell death reveals immunologic and prognostic characteristics of breast cancerSemantic proximity Read

Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patientsSemantic proximity Read

Comprehensive multi-omics analysis identifies an immune related predicting model in early stage breast cancerSemantic proximity Read

Integrative Analysis of Homologous Recombination Repair Patterns Unveils Prognostic Signatures and Immunotherapeutic Insights in Breast CancerSemantic proximity Read